- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
American Biogenetic pursues MH-1 agent
American Biogenetic Sciences of Boston is investigating the development of a new radiopharmaceutical for imaging pulmonary embolism. The company's MH-1 agent has completed phase I/phase II trials at Albany Medical Center, where preliminary results
American Biogenetic Sciences of Boston is investigating the development of a new radiopharmaceutical for imaging pulmonary embolism. The company's MH-1 agent has completed phase I/phase II trials at Albany Medical Center, where preliminary results indicate that the agent may improve detection of pulmonary embolism.
Some 600,000 people in the U.S. annually develop pulmonary embolism, which occurs when blood clots travel from other parts of the body and lodge in the lung. The disease is the third most common cause of death in the U.S., according to the company.
MH-1 is a technetium-labeled agent that may help physicians identify pulmonary embolism early by locating the source of the clot. A case report on the Albany Medical Center study is featured in the June issue of Clinical Nuclear Medicine, and the study was presented at last month's Society of Nuclear Medicine meeting in San Antonio.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
